New York-based Pfizer Inc. and BioNTech SE today announced they had submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in children 5 to <12 years... READ →
Precision Vaccinations/ September 28th, 2021
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Sep 28 • 1:27 pm CDT
Sep 28 • 11:57 am CDT
France-based Valneva SE and Pfizer Inc. today announced further positive Phase 2 study results, including booster vaccination response, for Lyme disease vaccine candidate VLA15. VLA15 is the only active Lyme disease vaccine candidate in clinical development... READ →
Sep 27 • 5:01 pm CDT
U.S. Secretary of Homeland Security Alejandro Mayorkas stated during an Operation Allies Welcome teleconference on September 24, 2021, 'All arrivals — U.S. citizens, lawful permanent residents, and Afghan nationals — are being tested for COVID-19 upon... READ →
Sep 27 • 4:05 pm CDT
A Texas-based radio show interviewed Governor Abbott on September 27, 2021, during which he revealed the state of Texas is procuring COVID-19 monoclonal antibody treatments directly from the manufacturer. The Dana Loesch radio program confirmed Texas... READ →
Sep 27 • 11:40 am CDT
Pennsylvania-based NRx Pharmaceuticals today announced top-line data demonstrating improved outcomes at one year in highly comorbid COVID-19 patients who were treated with ZYESAMI™. ZYESAMI (aviptadil) is a synthetic form of Vasoactive Intestinal Polypeptide. Between June and... READ →
For more articles, try our search.